Connect with us
During this first half of the year, Switzerland has fallen as the leading supplier of Spanish pharmaceuticals, giving way to the United States in first position, with...
Cardiol Therapeutics is rapidly advancing toward gaining FDA approval for its breakthrough heart treatment for multiple cardiovascular diseases — CardiolRx™. The company is leveraging FDA and...
Boehringer Ingelheim has developed this new obesity drug with Zealand Pharma. Survodutide works by mimicking a gut hormone called glucagon-like peptide-1, which suppresses appetite and helps...
Ipsen markets more than twenty medicines in more than 115 countries and has a direct commercial presence in more than 30 states. Ipsen's research and development...
Gilead said that it expects the agreement with Tentarix to reduce its earnings per share (EPS) from 3 to 4 cents in 2023. In addition, the...
Currently, the British multinational does not have any project related to this type of therapy. AstraZeneca tried to reach this market through a negotiation with Moderna, but...
Neuralink, Elon Musk's brain-computer interface startup, has just raised $280 million for its brain implant technology. Initially, Neuralink aims to treat Alzheimer's and paralysis. It will...
Roche recently partnered with Alnylam for the development and commercialization of a treatment for hypertension in patients with high cardiovascular risk. The Swiss company makes an initial...
Doctomatic uses artificial intelligence capable of reading data from images to find out if a person may or may not have a disease. The company's clients...
In 2023, Bayer hoped to have a sales volume of between €51 billion and €52 billion, which is now reduced to between €48.5 billion and €49.5 billion,...
 |
|
 |  |
 |
|